Alissa Baker, MD, is an Instructor in Pediatric Hematology/Oncology at Albert Einstein College of Medicine. Her clinical focus is in pediatric sarcomas with an interest in identifying biomarkers of metastases, as well as identifying new adjuvant therapies for this high-risk patient population. Dr. Baker joined the Montefiore team in 2018.
Dr. Baker received her Doctor of Medicine from Penn State College of Medicine. She completed her residency in Pediatrics at Yale-New Haven Hospital, where she led the Quality Improvement team for the Pediatric Hematology/Oncology unit. Following residency, she completed her fellowship in Pediatric Hematology/Oncology at Johns Hopkins Hospital and The National Institutes of Health.
Dr. Baker’s research focuses on Ewing sarcoma metastasis biology, with a specialized focus on Wnt signaling, using zebrafish as a model of sarcoma metastasis for high throughput drug screens to identify new agents, screening patient plasma and tissue samples for biomarkers of potential metastasis, and identifying circulating tumor cells in the blood of sarcoma patients as a possible correlative to disease burden. Her publications include a co-first author sentinel nature paper on mutation profiling in human cancer and a recent paper on the effects of Wnt signaling inhibition in Ewing sarcoma.
In 2017, Dr. Baker received the Pearl M. Stetler Grant for Women Physicians. In 2018, she received the Paul Calabresi K12 Award in Clinical Oncology for her research in Ewing sarcoma biology. Dr. Baker is board certified and an active member of the American Academy of Pediatrics. In addition, she is a member of the American Association for Cancer Research and the National Pediatric Cancer Foundation.